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Abstract
Introduction: The aim of this project was to systematically review UK evi-
dence on the effectiveness of long-term (≥12 months) weight management
services (WMSs) for weight loss and weight maintenance for adults
(≥16 years) with severe obesity (body mass index ≥35 kg m2), who would
generally be eligible for Tier 3 services.
Methods: Four data sources were searched from 1999 to October 2018.
Results: Our searches identified 20 studies, mostly noncomparative studies: 10
primary care interventions, nine in secondary care specialist weight manage-
ment clinics and one commercial setting intervention. A programme including
a phase of low energy formula diet (810–833 kcal day1) showed the largest
mean (SD) weight change at 12 months of –12.4 (11.4) kg for complete cases,
with 25.3% dropout. Limitations or differences in evaluation and reporting
(particularly for denominators), unclear dropout rates, and differences between
participant groups in terms of comorbidities and psychological characteristics,
made comparisons betweenWMSs and inferences challenging.
Conclusions: There is a persistent and clear need for guidance on long-term
weight data collection and reporting methods to allow comparisons across
studies and services for participants with severe obesity. Data could also
include quality of life, clinical outcomes, adverse events, costs and economic
outcomes. A randomised trial comparison of National Health Service Tier 3
services with commercial WMSs would be of value.
Introduction
In the UK, obesity is managed on a tiered path by
National Health Service (NHS) and community services.
Tier 1 includes universal prevention services, Tier 2
includes lifestyle interventions in primary care, Tier 3
includes specialist multidisciplinary weight management
services (WMSs) and Tier 4 includes bariatric surgery (1–
3). Although people with severe obesity are likely to
attend Tier 2 WMSs, having severe obesity (with or
without comorbidities), may be a referral criterion for
Tier 3 WMSs, prior to Tier 4 services (4,5). Although
adults with severe obesity may require more support with
weight management, current National Institute for Health
and Care Excellence (NICE) and Scottish Intercollegiate
Guidelines Network (SIGN) guidance on WMSs provides
little additional information for this group, apart from
very-low-energy formula diets (VLEDs) (providing
≤800 kcal day1) for people who need to lose weight
quickly (e.g. for joint replacement or fertility treatment)
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(3–9). VLEDs are rarely used in the NHS, although there is
increasing interest in the use of low energy formula diets
(LEDs) (800–1200 kcal day1). Prior attendance at a Tier
2 service may be a criterion for entering a Tier 3 service.
Effective services could reduce the numbers of patients
moving on to higher tiers of weight management or con-
tribute to the long-term effectiveness after bariatric sur-
gery. Our aim was to systematically review the UK
evidence base for long-term (≥12 months) behavioural
interventions for weight loss and weight maintenance for
adults with severe obesity [body mass index (BMI)
≥35 kg m2] and evaluate their effectiveness.
Materials and methods
The present study comprises an analysis of WMSs that are
Tier 3 services or similar to Tier 3 services (e.g. partici-
pants with a spread of obesity-related comorbidities and/
or BMI ≥35 kg m2) and is an updated version and a
subgroup of results from the National Institute for Health
Research funded REview of Behaviour And Lifestyle inter-
ventions for severe obesity: AN evidenCE synthesis (REBA-
LANCE) (10) project. A protocol was registered a priori
(PROSPERO No CRD42016040190). This systematic
review is reported following the PRISMA standard (11).
Inclusion criteria
Full-text reports of UK WMSs of any study design pub-
lished since 1999, in NHS clinical settings (e.g. primary
care, secondary care) or commercial organisations, with a
mean or median duration of ≥12 months of follow-up,
which included adults (mean or median age ≥16 years)
with a mean or median BMI ≥35 kg m2, were included.
Studies focusing on participants with only one type of
morbidity, as indicated by study inclusion and exclusion
criteria, were excluded to reflect generalisable interven-
tions for people with obesity and a range of comorbidities,
rather than condition-specific interventions, which would
also have a behaviour change focus tailored for specific
diseases, such as type 2 diabetes and weight management
and blood sugar monitoring. Weight loss or prevention of
weight regain after weight loss interventions (including
VLEDs and LEDs), other dietary treatment, physical activ-
ity, behavioural counselling or a combination of these
interventions were included. Interventions that included a
pharmacological component (e.g. orlistat) were included
only if this was offered as part of a WMS (i.e. studies were
excluded for which the purpose was to evaluate orlistat).
The primary outcome was weight change or BMI
change. Changes in secondary outcomes (e.g. cardiovascu-
lar risk factors) can be found in the full REBALANCE
report (10).
Literature searching
Literature searches were undertaken in four databases
(MEDLINE, EMBASE, PsycINFO and Clinical Trials.gov)
for interventions from 1999 to October 2018 (10,12,13).
ClinicalTrials.gov was searched for ongoing studies and
reference lists of included studies were scanned to identify
additional potentially relevant studies. Nineteen relevant
NHS and commercial organisations, including Dietitians
in Obesity Management, and the REBALANCE advisory
group were contacted to help identify further published
and unpublished reports. See REBALANCE report (10) for
full search strategies.
The first, second and last author of the main included
publications were contacted to identify additional materi-
als (e.g. protocols, trial materials) that would assist data
extraction.
Data extraction and quality assessment
Three reviewers (MA-M, CR and FS) independently
screened titles, abstracts and full text reports, with a 10%
check for agreement. The Template for Intervention
Description and Replication (TIDieR) checklist was used
for data extraction (14). Each reviewer extracted details of
study design, methods, participants, interventions and
outcomes, and TIDieR (14). A second reviewer (AA)
checked numerical data extraction. Data for weight
change are presented for complete cases, imputed estima-
tions, last observation carried forward or baseline obser-
vation carried forward, as presented by authors.
Three reviewers (MA-M, CR and FS) conducted a dou-
ble-blinded quality assessment of the included studies.
The Cochrane risk of bias tool was used to assess ran-
domised controlled trials (RCTs) (15) and a 17-question
quality assessment tool (ReBIP) was used to assess non-
randomised comparative and case series studies (16). An
adapted version of the Campbell and Cochrane Equity
Methods Group checklist (17) was used to assess the effect
of interventions on disadvantaged groups and/or their
impact on reducing socio-economic inequalities.
Results
Our searches identified 4078 potentially relevant titles and
abstracts. From these, 20 (18–38) studies were included
(Fig. 1). Four were RCTs (18,26,29,33), one (34) was a 9-
month RCT after a 3-month nonrandomised screening
period and the remaining 15 were observational studies.
General characteristics of the included studies are pro-
vided in Appendix 1. Ten WMSs were delivered in NHS
primary care settings (18,21–23,25,26,28,29,31,32). Nine were
secondary care interventions at specialist weight
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management clinics (19,20,24,27,30,33,35,37) and one was a
commercial setting intervention (34). Some 65% of the
studies took place in England, 25% in Scotland and 10%
in more than one country of the UK.
Characteristics of the participants
In total, 22 406 participants started interventions and 8982
were included in the analyses at final follow-up, although
numbers were sometimes unclearly reported. Two studies
included only women (30,31). Sample size varied from 84
(31) to 6715 (22) participants. Women represented 76.1% of
the total population. The average participant age (weighted
mean) was 48.4 years. The youngest reported mean age was
39.9 years (33) and the oldest was 55.8 years (23). The aver-
age BMI (weighted mean) of all participants was
39.9 kg m2, the lowest (31) reported mean BMI was
35 kg m2 and the highest(37) was 50 kg m2. Of note,
8.2% of women included in the study by Cartwright (20)
had a BMI ≥60 kg m2.
Three studies (21–23) did not report exclusion criteria.
One trial (18) and one study (32) excluded participants
using pharmacological treatment for obesity (e.g. orlistat),
whereas three others offered orlistat as an optional drug
treatment within the intervention.(25,28,29) One of the pri-
mary care trials excluded participants with a BMI
≥45 kg m2 (29) and one trial excluded participants with
a perceived incapability of walking 100 m (26). One trial
(26) and one study (31) reported excluding participants
with psychiatric conditions (including eating disorders).
Although the main shared participant characteristic of
the included reports was a mean BMI ≥35 kg m2, partici-
pants varied in terms of obesity-related comorbidities. For
example, the prevalence of type 2 diabetes among partici-
pants was reported by 12 studies; (18,22,24,26,28,29,32,36,37)
ranging from 9% (29) to 34.4% (28). Other reported
Database searches
MEDLINE/Embase     n = 3625
PsycINFO                    n = 2643
Total                            n = 6268
After deduplication     n = 3452
Included 
studies
n = 20
Excluded studies
n = 81
Not UK Studies                                    n = 16
BMI <35 or unclear                              n = 23
Not lifestyle intervention/unclear       n = 20
Assessment <12 months                     n = 8
No data                                         n = 2
Not obtained                                        n = 4
Orlistat trials             n = 3
Prior to 1999                                  n = 1
Participants with specific condition n = 4
(e.g. diabetes only) 
Excluded
n = 3364
Selected for full text 
assessment
n = 101
Figure 1 PRISMA diagram. BMI, body mass index.
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comorbidities were hypertension (18,21,24,32,36,37), impaired
fasting glucose (21,23,24), cardiovascular disease (20,21,29,36,37)
and dyslipidaemia (19,21,36). Other comorbidities reported
were arthritis (20,37), joint pain (36,37), sleep apnoea (20,24,36),
depression (24,36) and asthma (37). Some studies
(25,27,31,33,35) did not report any comorbidity.
Assessment of risk of bias
The overall methodological quality was poor across stud-
ies (Figs 2 and 3). In four RCTs(18,26,29,31), many of the
domains were assessed as being at a high risk of bias
(Fig. 2). Only just over half of these studies (52.6%) pro-
vided information on participant dropouts.
Assessment of equity and sustainability
Half (50%) of the studies were conducted in settings that
might target or exclude specific populations. Most (65%)
did not report socio-demographic differences between
completers and withdrawals/dropouts, although 75%,
reported details for some PROGRESS categories (Place of
residence, Race/ethnicity, Occupation, Gender, Religion,
Education, Socio-economic status, or Social capital). Few
(25%) considered sustainability, although 60% discussed
their interventions in organisational contexts. Five studies
(22,25,30,32,36) reported organisational partnerships (e.g.
NHS, commercial organisations, local authorities and
community groups) (Fig. 4).
Few studies assessed the fidelity of intervention delivery
or participant adherence to interventions, and few
reported intervention-related adverse events. Potential for
conflict of interest was unclear in 15% of studies.
One trial (Cambridge Weight Plan UK) (18) and one
study (LighterLife Company) (25) received partial or full
financial funding from the intervention manufacturer. In
two further studies (24,36), no conflict of interest was
declared, but Cambridge Weight Plan UK donated
products.
Sequence generation (selection bias)
Allocation concealment (selection bias)
Blinding of participants (performance bias)
Blinding of health-care providers (performance bias)
Blinding of outcome assessment (detection bias)
Incomplete outcome data (attrition bias)
Selective reporting
Other bias
Risk of bias of RCTs
High Unclear Low
Figure 2 Risk of bias of randomised controlled trials (RCTs).
Representative sample
Inclusion and exclusion criteria
Participants at similar point in disease progression
Selection of participants consecutive
Data collection undertaken prospectively
Groups comparable
Intervention clearly defined
Intervention delivered by experienced person
Intervention delivered in an appropriate setting
Important outcomes considered
Objective outcome measures used
Assessment of main outcomes blind
Follow-up long enough
Information on non-respondents, dropouts
Withdrawals likely to introduce bias
Length of follow-up similar between comparison groups
Important prognostic factors identified
Analyses adjusted for confounding factors
Risk of bias non-comparative studies
Yes No Unclear NA
Figure 3 Risk of bias of nonrandomised comparative studies and case series.
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Assessment of effectiveness
As a result of study heterogeneity, a narrative overview is
presented according to the setting where the intervention
was delivered.
National Health Service primary care
Across primary care services, 10 eligible studies (18,21–
23,25,26,28,29,31,32) were identified. Most of these studies
were undertaken in England, with the exception of two
(21,28) undertaken in different sites across the UK, as well
as two (22,25) in Scotland. In all cases, primary care prac-
tices were involved as the main setting of the studies,
except one (28) that not only mainly recruited participants
from primary care settings, but also included participants
from commercial services (i.e. one commercial weight-
management service and recruitment through eight free-
lance Counterweight-Plus trained practitioners). Women
made up the majority of participants in primary care
studies (over 60%) and one study recruited only
women.(31)
The interventions were mainly delivered in primary
care practices to individuals. One study also applied the
intervention in pharmacies and community settings (22).
The main care providers were nurses (21–23,25,26,28), dieti-
tians (21,22,25,28,31,32), general practitioners or psychologists
(29,31). One trial described the intervention provider as a
‘LED counsellor’ (18). One study of primary care interven-
tions incorporated other professionals, such as an exercise
scientist (31). In most cases, the interventions were
delivered individually, although three studies imple-
mented group sessions (29,31,32).
One trial (18) and two (25,28) studies evaluated the effi-
cacy of LEDs in primary care, the latest in addition to the
Counterweight programme (25,28). In these three cases, the
Cambridge Weight Plan/Counterweight PRO800 UK LED
was offered (LED with 810–833 kcal day1) and, in the
study by Lean et al. (25), an option of an 810 kcal day1
homemade LED was also available. Few of the interven-
tions defined the nutritional characteristics of the dietary
advice/or nutritional programme in depth (18,21,22,25,28,31).
Similarly, only one intervention provided in depth detail
on the physical activity plan offered to participants (28).
General characteristics of the included studies delivered
in the primary care studies are provided in Appendix 1.
Overall weight, percentage of weight and BMI change are
presented in Table 1.
In primary care, studies that provided LEDs were those
with the higher weight loss. For example, after 12 months
of follow-up, Lean et al. (25) reported a mean (SD) weight
loss of 12.4 (11.4) kg for completers with 25.3% drop out
from baseline. A similar result was reported by Astbury
et al. (18) where those participants randomised to LED
were reported to have a mean (SD) weight loss of 10.7
(9.6) kg for completers [10.2 (9.7) kg by multiple impu-
tation] and a dropout rate of 24.6%. In another study
incorporating a LED, McCombie et al. (28) reported a
mean (SD) weight loss of 14.2 (11.6) kg at 12 months for
complete cases [10.5 (9.5) kg imputed data] with a
dropout rate of 44.2%.
PROGRESS= Place of residence; Race/ethnicity/culture/language; Occupation; Gender/sex; Religion; Education; Socioeconomic status; Social capital
Equity pointer
Representativeness
Sociodemographic differences
PROGRESS categories
Diversity/disadvantage strategies
Fidelity check
Process evaluation
Providers reported
Sustainability
Political/organisational
Referred partnerships
Author conflict
Harms/unintended effects
Equity and sustainability appraisal
Yes No Not reported Unclear
Figure 4 Equity and sustainability appraisal.
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From those interventions that did not include VLEDs
or LEDs, higher reported weight losses were associated
with higher dropout rates, which reflected selective
reporting of results. Most primary care studies that did
not include VLEDs or LEDs achieved weight losses at
12 months of 2–4 kg mostly for complete cases and drop-
out rates of 20–30%, with the exception of Counterweight
studies where dropout rates were 55–72% at 12 months.
Secondary care (specialist weight management clinics)
Nine studies evaluated specialist weight management clin-
ics in the UK (19–21,24,27,30,35–37). Seven of these services
were delivered in England and two were in Scotland
(27,33). Only one study was conducted as a RCT (33).
All WMSs included multidisciplinary teams (mainly a
physician with a special interest in obesity, dietitians,
and psychologists) and offered a similar service (be-
havioural therapy, including reduced calorie diets, LEDs,
VLEDs and, in some cases, orlistat). Some interventions
were delivered as individual sessions (20,27,33,37), two
were delivered as group sessions (19,30), and three were
delivered as both individual and group sessions (24,35,36).
Some of the interventions were delivered in general
practitioner practices in the community (20) or in local
gyms (24). Only four studies provided weight data after
12 months of follow-up (19,20,24,37). Dropout rates, where
clearly provided, ranged from 45% (24) to 78.3% (35)
over the first 12 months.
Some interventions included an initial period with
LED, and a follow-up period with psychological and die-
tetic support.(18,25,28) The number of contacts followed a
similar pattern: intensive initial care (approximately the
first 3 months) and then fortnightly or monthly meetings,
comprising five to 15 contacts in the first 12 months.
Overall weight, percentage of weight and BMI change
are presented in Table 2.
Rolland et al. (33) implemented a RCT. Patients ini-
tially underwent a dietary treatment with a low-fat,
600 kcal day1 deficit diet for 3 months. If patients
responded well to this method, it was continued for the
next 9 months. If patients failed to lose weight, they
were randomised either to LighterLife VLED
(550 kcal day1) plus a weekly group support activity or
a low carbohydrate/high protein (800–1500 kcal day1)
diet for the next 9 months with six contacts over
9 months. After 12 months, participants who responded
well to the initial low fat, 600 kcal day1 deficit diet
(and were not randomised), had the highest weight
change of all participants within this trial
[17.5 (6.4) kg] and across the other studies set in sec-
ondary care clinics, although the dropout rate was
unclear for this group. 12-month weight loss in the
VLED group was 16.1 (19.0) kg compared to
3.0 (6.7) kg for the low carbohydrate high protein diet.
Dropout rates were also unclear for these groups.
Across other studies that included a LED or VLED,
weight loss varied from 5.1 kg (30) to 13.4 kg (19) after
12 months; however, the dropout rates were either
unclear or over 69%.
Commercial setting
Only one study was conducted outside the NHS setting.
Rolland et al. (34) retrospectively assessed the effect of
LighterLife Total VLED with group-based behaviour
therapy for self-referred participants who completed
1 year of treatment. The initial weight loss phase could
vary from weeks to several months, continued by
weekly group meetings. The mean (SD) weight change
from baseline was 12.9 (11.3) kg at 36 months, pre-
sumed for completers; dropout rates were unclear. Over
50% of participants returned to the weight loss phase
for a second attempt during the 36-month period
(Table 3).
Discussion
We attempted to comprehensively review studies relevant
to Tier 3 WMSs for adults with higher BMIs. One previ-
ous systematic review of Tier 3 weight loss services for
adults by Brown et al. (38) included 14 studies with wider
BMIs and shorter follow-up. Our focus was somewhat
different, looking at longer-term outcome data from ser-
vices relevant to adults with a BMI ≥35 kg m2. The dis-
tinction between Tier 2 and Tier 3 services appears to be
blurred. Two specialist weight management services (27,35)
explained that participants needed to undertake a pro-
gramme similar to Tier 2 services before entering their
Tier 3 programme. Primary care services offered pro-
grammes to participants whose mean was BMI
≥35 kg m2 with a range of comorbidities; these pro-
grammes were difficult to distinguish from those for par-
ticipants in secondary care specialist weight management
services in the studies reported here.
Only 35% of our included studies reported data
beyond 12 months; the absence of long-term data in the
remaining studies is problematic with repect to evaluating
the long-term effectiveness of these interventions. Limita-
tions or differences in evaluation and reporting, as well as
differences between participant groups in terms of
comorbidities and psychological characteristics, made
comparisons and inferences between studies and interven-
tions challenging, and precluded meta-analysis. There is a
need to improve data collection data in these interven-
tions. Long-term data collection has been a challenge, in
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terms of funders providing resources to allow this to hap-
pen.
Across studies, LEDs were associated with the greatest
weight losses; for example, a mean weight change of
–12.4 kg at 12 months in the study by Lean et al. (25), with
a reported dropout rate of 25.3% (25), as well as similar
results in the study by Astbury et al (18). Dropout rates
tended to be lower with LEDs, which could suggest that
better weight loss with these diets provided participants
with more motivation to continue in the weight manage-
ment programme. Unclear denominators in studies with
the LighterLife VLED do not allow comparisons with other
VLED (19,33) studies. Only one trial (26) described expressly
considering participants’ choices or motivations for
improving engagement with starting or continuing services.
By contrast, one study (24) reported excluding participants
‘by their lack of motivation’. Motivation (or lack of it) is
sometimes assessed before participants are included in ser-
vices, and so it would be helpful for authors to be explicit
about this assessment and the referral pathway. Changing
dietary advice according to how the weight of participants
responds to different dietary interventions also appears to
be beneficial for weight loss (33).
Socio-demographic characteristics were often not
reported and few studies appeared to include hard to
reach or disadvantaged groups (e.g. ethnic groups, people
with disabilities, younger or older people) or participants
with a BMI >40 kg m2.
All studies included both men and women, except for
two women-only studies (30,31). Overall, more women
(76.1%) were recruited than men in the remaining stud-
ies. Evidence was insufficient to assess whether specific
services for men or women would be more effective. One
study, which was not included in this review, reported
the results obtained in a community intervention deliv-
ered in football clubs to men with mean BMI of
35 kg m2 (39). Exceptionally, this trial showed little evi-
dence of weight regain by 12 months; weight loss
5.6 (8.1) kg, 11.0% dropout at 12 months. The results of
this study indicate that WMSs that are tailored for men
could be particularly effective. Few interventions reported
considering ‘emergency plans’ or contact after the inter-
vention, if needed.
Dietary and physical activity interventions were poorly
described, making programme reproduction difficult. One
study (19) and one trial (29) did report participants’ weight
loss history (including number of past weight loss
attempts, methods used, average weight lost). Some stud-
ies excluded participants with eating disorders (31,33,34). In
one trial, participants were able to choose their diets (26).
Important features of the diets (e.g. availability; afford-
ability; preferences; behavioural, social and economic
costs for participants) were not described. These factorsTa
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could impact on intervention effectiveness and adherence.
Similarly, the extent to which diets were tailored may
influence not only their success, but also their ease of
delivery.
One study (24) and one trial (26) provided information
on physical activity advice provided to participants; how-
ever, in most cases, details of physical activity advice were
either poorly reported or not reported at all. One trial
excluded participants with inability to walk more than
100 m (26). Others included participants with arthritis
(20,37) or joint pain (36,37), factors to consider when rec-
ommending physical activity.
Scaling up interventions to reach more participants is
important, particularly from an NHS perspective. Little
et al. (26) showed that remote delivery produced much
the same 12 month weight change compared to face-
to-face delivery with a dropout rate of under 20%
(mean 3.2 kg and 3.8 kg, respectively, for com-
pleters). This is comparable to the 12-month weight
loss in the Counterweight evaluations (21,22), which had
dropout rates of 54.8% to 72%, although these are
smaller weight losses than those reported in UK RCTs
of commercial WMSs in primary care, with dropout
rates from 11% to 29.5% (38,40). Similarly, given that
primary care referral to a commercial provider for par-
ticipants of mean BMI 34.6 kg m2 (in a RCT
excluded from our review) demonstrated a weight loss
of 4.9% from 12 weeks of programme at 12 months
(100% of participants) and 7.1% from 52 weeks of
programme (data for all participants), the role of com-
mercial providers for people with higher BMIs could be
explored further (41). A comparison of Tier 3 services
with commercial WMSs would be of value, considering
the possible methodological challenges that this might
comprise (particularly data collection and drop-out
rates). Long-term UK data are urgently needed for par-
ticipants with severe obesity (e.g. LighterLife, Cam-
bridge Weight Plan, Weight Watchers, Slimming World,
Counterweight Ltd) with weight outcomes taking
account of dropouts. Randomised evaluations of com-
parisons of different approaches, including existing Tier
3 specialist WMSs, or allowance for the choice of
reducing diet, would be valuable.
None of the included studies reported adapting the
intervention to the needs of participants. Interventions
appear to have been designed according to the resource
availability or capability of the weight management sys-
tem. For example, none of the studies reported attending
participants out of the practice’s regular attendance hours
(e.g. evening or weekends), to facilitate participation.
There is a clear need for guidance on weight data col-
lection and reporting to allow comparisons across studies
and services. It was difficult to make comparisons
between services, particularly when data were not pro-
vided for all participants (e.g. by last observation carried
forward or baseline observation carried forward, which
correct for differences in dropout rates). Services should
be funded to collect data for longer than 1 year, prefer-
ably for 5 years. Public Health England has guidance for
the evaluation of weight loss services (42) and a core out-
come set has been developed in the UK using consensus
methods, including advice on weight change data collec-
tion and statistical analysis (43,44). Data should include
quality of life, clinical outcomes, adverse events, costs and
economic outcomes in a standard format. More detailed
guidance on the content of reported WMSs would be
very valuable, aiding with replication and evaluation.
In summary, our searches identified 20 studies, which
were mostly noncomparative. A programme including a
phase of low energy formula diet low energy diet showed
the largest mean weight change at 12 months of
12.4 (11.4) kg with 25.3% dropout. Differences in eval-
uation and reporting (particularly for denominators),
unclear dropout rates, and differences between participant
groups in terms of comorbidities and psychological char-
acteristics, make comparisons between different pro-
grammes very challenging. There is a persistent and clear
need for guidance on long-term weight data collection
Table 3 Overall weight change, percentage weight change and body mass index (BMI) change in commercial setting, presumed data for
completers
Study ID Intervention arm
Outcome
measured
Baseline outcome,
mean (SD) n
12-month
Outcome,
mean (SD)
[% dropout]
24-month
Outcome,
mean (SD)
[% dropout]
36-month
Outcome,
mean (SD)
[% dropout]
Rolland 2014 (34)
LighterLife
VLED
(550 kcal day1)
Weight (kg) 99.1 (16.6) n = 5965 18 (11.4)
[Unclear]
14.9 (11.4)
[Unclear]
12.9 (11.3)
[Unclear]
Weight change (%) – 17.6 (9.5) 14.7 (10) 12.9 (10)
BMI (kg m2) 36.3 (5.1) 6.6 5.4 4.7
VLED, very-low-energy formula diet (<800 kcal day1).
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and reporting methods to allow comparisons across stud-
ies and services for participants with severe obesity.
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Appendix 1
Study (first author, year,
reference) Study characteristics Participant´s characteristics Intervention characteristics
Primary care services
Astbury 2018 (18)
Doctor Referral of
Overweight People to
Low
Energy total diet
replacement Treatment
(DROPLET) Study
Location: Primary care practices in
Oxfordshire, England
Design: Pragmatic, two arm,
parallel group, open label,
individually randomised controlled
study
Period of the study: 2016–2017
Recruitment: Participants sourced
from 10 practices
Number of participants
allocated: 278 (intervention:
138, control: 140)
Inclusion criteria: BMI
≥30 kg m2and age ≥18 years
Exclusion criteria: People who had
received or were scheduled for
bariatric surgery, in a weight
management programme, or with
contraindications to the dietary
intervention
Baseline age, mean (SD): 37.2
(5.4)
Comorbidities at baseline: 23%
had hypertension and 15% had
diabetes
Delivered by: Intervention:
untrained ‘counsellors’ and
clinicians. Control: nurses
Description: Intervention group: 8
initial weeks with a LED
(810 kcal day1), followed by
4 weeks of food reintroduction.
Regular behavioural support was
offered. Usual care: Series of
appointments for behavioural
weight management advice for 12
weeks
Duration of active intervention:
24 weeks
Length of follow-up (months): 12
Jackson 2007 (23) Location: A moderately deprived
health centre from West
Yorkshire, England
Design: Prospective study
Period of the study: 2003–2004
Recruitment: Participants were
referred to the clinic by the family
physicians, practice-based nurses
and health visitors
Number of participants
allocated: 89
Inclusion criteria: BMI >35 kg m2
or BMI >30 kg m2 with associated
comorbidities
Exclusion criteria: NR
Baseline age, mean (SD): 55.8
(13.8)
Comorbidities at baseline: 13.5%
had impaired fasting glycaemia
Delivered by: Public health nurse
Description: The goal of the clinic
was to deliver a specialist health
visitor-led, nonpharmacological
intervention to adopt a healthier
lifexmlstyle through healthy eating
and increasing physical activity
Duration of active intervention:
Appointments within 3 weeks of the
initial referral, then at two weekly
intervals for 12 months. Contact
after 12 months was negotiated,
depending on need
Length of follow-up (months): 12
Read 2004 (32) Location: Three health centres in
the north locality of Nottingham
City Primary Care Trust, England
Design: Prospective study
Period of the study: 2000–2002
Recruitment: GPs and practice
nurses could refer patients
opportunistically or patients could
refer themselves
Number of participants
allocated: 216
Inclusion criteria: 18–65 years old,
BMI >30 kg m2 with associated
comorbidities
Exclusion criteria: current use of
obesity medication, insulin
treatment of diabetes, pregnancy,
and attendance at a hospital
obesity clinic
Baseline age, mean (SD): 50.4
(12.4)
Comorbidities at baseline: 57%
had hypertension, 25% had
diabetes, 10% had angina, 9% had
previous myocardial infarction
Delivered by: Dietitian and nurse
Description: Individual assessment
appointment before commencing
the group sessions. Seven 2-hour
education and support group
sessions to improve lifestyles run by
the dietitian at intervals of 2 weeks.
Further 2-hour sessions were
delivered at 4, 6, 9, and 12 months,
Duration of active intervention:
12 months
Length of follow-up (months): 12
McRobbie 2016 (29)
The Weight Action
Programme (WAP)
Location: Six GP surgeries from
areas with high levels of social
deprivation across London,
England
Design: Randomised controlled
trial
Period of the study: 2012–2015
Inclusion criteria: Age ≥18 years
and BMI of ≥30 kg m2 or ≥
28 kg m2 with associated
comorbidities
Exclusion criteria: BMI of
>45 kg m2, had lost > 5% of
weight in the previous 6 months,
Delivered by: Intervention health
psychologists. Control GPs and
practice nurses
Description: Intervention group-
based weight loss programme (10–
20 participants) delivered over eight
weekly group sessions followed by
10 monthly maintenance sessions
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Appendix Continued
Study (first author, year,
reference) Study characteristics Participant´s characteristics Intervention characteristics
Recruitment: Primarily recruited
from the practices, and further
advertising was made
Number of participants
allocated: 330 (intervention:
214, control: 116)
were pregnant, were taking
psychiatric medications
Baseline age, mean (SD):
Intervention 46.6 (15.0) Control
45.1 (14.2)
Comorbidities at baseline:
Intervention 10% had heart
disease, 10% had diabetes Control
6% had heart disease, 8% had
diabetes
that combine standard cognitive
behavioural interventions, dietary
advice and self-monitoring with
group-oriented interventions.
Control Best practice intervention
incorporating national guidelines
and NHS materials in four one-to-
one sessions delivered over 8 weeks.
Orlistat was an option to
participants in both groups
Duration of active intervention:
Intervention 12 months Control 8
weeks
Length of follow-up (months): 12
Rapoport 2000 (31) Location: GP surgeries or local
health clinics (geographical
location not specified), England
(by authors affiliation)
Design: Randomised controlled
trial
Period of the study: Prior to
2000
Recruitment: through letters to
GP, posters in health centres and
notices in the local media
Number of participants
allocated: 75 (intervention
[modified cognitive-behavioural
therapy]: 37, control [standard
cognitive-behavioural therapy]:
38)
Inclusion criteria: Women aged
18–65 years and BMI of
≥28 kg m2
Exclusion criteria: being involved in
any other method of weight
management, serious medical or
psychiatric conditions (including
eating disorders), insulin dependent
diabetes, and pregnancy or
lactation
Baseline age, mean (SD):
Intervention 49 (10) Control 46 (12)
Comorbidities at baseline: None
reported
Delivered by: Registered dietitian
and a health psychologist, a clinical
psychologist and an exercise
scientist
Description: Both treatment
programmes involved weekly, 2h
sessions over a 10-week period,
with around 10 participants in each
group. Intervention: The programme
emphasised regular physical activity
and healthy eating as means to
improve overall health rather than
focusing in weight loss using used
basic behavioural and cognitive
principles incorporating incorporated
elements from psychoeducational,
nondieting and feminist approaches.
Control: Moderate energy deficit
giving approximately
1200 kcal day1. Participants were
asked to set specific weight loss
goals, basic behavioural and
cognitive principles
Duration of active intervention:
10 weeks
Length of follow-up (months): 12
Little 2017 (26)
POWeR+ (Positive Online
Weight Reduction)
Programme
Location: General practices
around the centres of
Southampton and Oxford,
England
Design: Randomised parallel-
group study
Period of the study: 2013–2014
Recruitment: General practices
identified participants from their
electronic records, and up to 100
patients from each practice were
randomly chosen and invited by
letter
Number of participants
allocated: 826 (intervention
Inclusion criteria: BMI of
≥30 kg m2 or ≥ 28 kg m2 with
associated comorbidities
Exclusion criteria: Major mental
problems, very severe illness
(difficulty completing outcomes and
were unable to change diet), were
pregnant or breastfeeding, or had a
perceived inability to walk 100 m
Baseline age, mean (SD):
intervention [face-to-face]: 53.7
(13.2), intervention [remote]: 54.7
(13) control: 52.7 (13.3)
Comorbidities at baseline: 17% in
the intervention [face-to-face], 16%
Delivered by: Nurses
Description: Control: advice and
simple materials to support
behaviour change. Intervention
[face-to-face]: Web intervention to
teach patients self-regulation and
cognitive behavioural techniques to
form sustainable eating and physical
activity, 24 web-based sessions
designed to be used over 6 months.
Participants had three scheduled
face-to-face appointments in the
first 3 months and then up to four
more during the next 3 months.
Intervention [remote]: Patients could
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Study (first author, year,
reference) Study characteristics Participant´s characteristics Intervention characteristics
[face-to-face]: 269, intervention
[remote]:270 control: 279)
in the intervention [remote] and
17% in the control group had
diabetes
access the same web-based
intervention as in the face-to-face
group and the intervention was to
assess whether even briefer
professional support for the web
intervention could be effective. In
addition to 6 monthly weighing, as
in the control group, participants
had three scheduled telephone or e-
mail contacts and up to two
optional telephone/e-mail contacts
during the first 6 months)
Duration of active intervention: 6
months
Length of follow-up (months): 12
Ross 2008 (21)
Counterweight Programme
Project (UK)
Location: 65 general practices
from
seven UK regions
Design: Prospective study
Period of the study: 2000–2005
Recruitment: Patients were
identified by GPs and practice
nurses during normal
appointments
Number of participants
allocated: 1906
Inclusion criteria: Age 18–75 years
and a BMI of ≥30 kg m2 or ≥
28 kg m2 with associated
comorbidities
Exclusion criteria: Not reported
Baseline age, mean (SD): 49.4
(13.5)
Comorbidities at baseline: 13.5%
had diabetes, 32.1% had
hypertension, 12.5% had
dyslipidaemia, 8% had
cardiovascular disease and 9.9%
had impaired glucose
Delivered by: Practice staff (GPs,
nurses and healthcare assistants)
trained by registered dietitians with
expertise in obesity management
Description: The practice nurse/
healthcare assistant role was to
deliver patient education through
discussion about weight
management, communication of
information, and the transfer of
behaviour change skills and
strategies during weight
management sessions. The aim was
to achieve an energy deficit of 500–
600 kcal day1. Participants were
asked to commit to nine
appointments in 12 months
(included six initial appointments of
10–30 minutes each, with follow-up
visits at 6, 9 and 12 months)
Duration of active intervention:
12 months
Length of follow-up (months): 24
Ross 2012 (22)
Counterweight Programme
Project (Scotland)
Location: 13 Health Boards
(including 184 general practices,
16 pharmacies), Scotland. Mainly
delivered in general practices, but
one Health Board chose a
pharmacy setting and another
favoured community-based
implementation of the
programme
Design: Prospective study
Period of the study: 2006–2008
Recruitment: Counterweight
Programme was positioned
alongside ‘Keep Well’ for practice
recruitment and screening of
patients
Number of participants
allocated: 6715
Inclusion criteria: 40–64 years
(specification for the ‘Keep Well’
programme), BMI of ≥30 kg m2
or ≥ 28 kg m2 with associated
comorbidities
Exclusion criteria: Not reported
Baseline age, mean (SD): 53.0
(10.4)
Comorbidities at baseline: From
those enrolled by 16 community
pharmacies (n = 458), 11.6 % had
diabetes
Delivered by: Practice staff (GPs,
Nurses and healthcare assistants)
trained by registered dietitians with
expertise in obesity management
Description: As described previously
(see Ross et al. (21)).
Duration of active intervention:
12 months
Length of follow-up (months): 12
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Lean 2013 (25)
Feasibility study for
Counterweight Plus
programme
Location: Practices already
delivering Counterweight,
predominately in rural
or small-town settings in Scotland
Design: Prospective study
Period of the study: Prior to
February 2013
Recruitment: Participants were
proposed by GPs, practice nurses,
or local dietitians
Number of participants
allocated: 91
Inclusion criteria: 20–60 years with
BMI ≥40 kg m2
Exclusion criteria: pregnancy or
lactation, diabetes and taking
insulin, myocardial infarction
cancers, chronic pancreatitis,
alcohol dependence, psychiatric
illness, and learning disability
Baseline age, mean (SD): 45.7
(10.7)
Comorbidities at baseline: Not
reported
Delivered by: Practice nurses,
physicians and dietitians
Description: The intervention was
delivered in practices that were
delivering the Counterweight
programme (see Ross et al. (22)).
There was an initial phase of 12
weeks of LED (810–833 kcal day1)
with weekly appointments for the
first 12 weeks. Then a food
reintroduction phase of 6–8 weeks
with one 360–400 kcal meal day–1
followed by a weight maintenance
phase of 34 weeks. All nutrition
from food was based on
individualised food portion plan
based on 500–600 calorie
deficit day–1 with an upper limit of
2500 kcal day1 in the last phase.
30 min per day of moderate
physical activity was encouraged.
Telephone support was provided if
necessary. Orlistat was optional for
participants
Duration of active intervention:
12 months
Length of follow-up (months): 12
McCombie 2019 (28)
Counterweight-Plus
Programme Project (UK)
Location: A variety of UK
providers
Design: Prospective study
Period of the study: 2013–2018
Recruitment: Participants
recruited from nine UK Health
Service areas, one private weight
management service, eight
private freelance Counterweight-
Plus trained practitioners
Number of participants
allocated: 288
Inclusion criteria: Age 18–75 years
and a BMI of ≥30 kg m2 or ≥
28 kg m2 with associated
comorbidities
Exclusion criteria: Active mental
illness, myocardial infarction or
stroke within the previous 3
months, severe or unstable heart
failure, porphyria, pregnant and
until >4 months post-partum,
breastfeeding, substance abuse or
eating disorder accompanied by
purging
Baseline age, mean (SD): 45.7
(12.7)
Comorbidities at baseline: 34.4 %
had diabetes (97% type 2 diabetes
and 3% type 1 diabetes)
Delivered by: registered healthcare
professionals (mainly registered
dietitians) with specialist training in
weight management, with access to
consultant physician expertise
Description: Seven 60 min
appointments over 12 weeks (or up
to 20 weeks if greater weight loss
required), where LED (825–
853 kcal day1) products and
written resources are provided. Then
a food reintroduction phase with six
appointments of 20 min over 6–12
weeks. Increased physical activity,
30 min of moderate activity day–1 at
least 5 days/week. Once achieved,
aim for 45–60 min of moderate
activity day–1 (monitoring with step-
counters or activity trackers if
possible). Orlistat available
depending on local prescribing
access. Seven appointments given to
consolidate behavioural change
strategies and restrict weight regain
Duration of active intervention:
12 months
Length of follow-up (months): 12
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NHS Specialist Weight Management Clinics (Secondary Care)
Barrett 1999 (19) Location: The Luton and
Dunstable Hospital specialist
multidisciplinary obesity services,
England
Design: Retrospective study
Period of the study: Prior to
1999
Recruitment: Patients referred by
General Practitioners
Number of participants
allocated: 115
Inclusion criteria: Referral to the
clinic was often prompted by
physical health problems related to
obesity
Exclusion criteria: Lack of
motivation or an eating disorder
Baseline age, mean (SD): 42 (NR)
Comorbidities at baseline: 34%
had hypertension; 11% had non-
insulin dependent diabetes and
41% had dyslipidaemia
Delivered by: Consultant physician,
clinical psychologist and a senior
dietitian
Description: Seven closed group
sessions providing formalised
behaviour and cognitive
modification combined with an
initial VLED (600–800 kcal day1).
Pharmacology treatment was given
upon evaluation. After completing
12-week programme, patients
returned to clinic at 3-month
intervals for advice and weighing.
Duration of active intervention:
12 weeks
Length of follow-up (months): 18
Cartwright 2014 (20) Location: Specialist Weight
Management Heart of England
NHS Foundation Trust and the
former South Birmingham Primary
Care Trust (but the programme
was delivered at local general
practices), England
Design: Prospective study
Period of the study: 2008–2012
Recruitment: Patients referred
from primary care settings in
West Midlands
Number of participants
allocated: 262
Inclusion criteria: Age 19–76 years
with BMI of ≥40 kg m2 or ≥
35 kg m2 with associated
comorbidities
Exclusion criteria: Not reported
Baseline age, mean (SD): 43.1
(11.8)
Comorbidities at baseline: 26.3%
had diabetes, 11.1% had
cardiovascular disease, 34.4% had
hypertension, 24% had arthritis,
and 25.6% had obstructive sleep
apnoea
Delivered by: Physicians, dieticians
and a psychologist
Description: Comprehensive
multidisciplinary care delivered
through individual appointments at
GP practices. The frequency of
contact was every three months,
but varied with individual
requirements and session availability,
with individuals attending
subsequent appointments every two
to three months or more frequently
if needed. Totalling a range of
contacts from 5 to 13
Duration of active intervention:
12 months
Length of follow-up (months): 36
Rolland 2009 (33) Location: Specialist Obesity Clinic,
Scotland
Design: Randomised controlled
trial
Period of the study: Prior to
2009
Recruitment: Patients were
referred by primary care services
Number of participants
allocated: 120 (After three
months: VLED group 34, Low
carbohydrate group 38, Energy
deficient group 18)
Inclusion criteria: Age over
18 years with BMI of ≥35 kg m2
Exclusion criteria: history of
hepatic or renal disease, cancer,
currently pregnant or lactating, on
antidepressants or anti-obesity
medication, eating disorders
Baseline age, mean (SD): Not
available for the whole sample.
VLED 39.9 (10.4), Low-
carbohydrate group 42.7 (13.1)
Comorbidities at baseline: Not
reported
Delivered by: Physician and dietitian
Description: Patients initially
underwent a dietary treatment with
a low fat, 600 kcal day1 deficit
diet for three months. If patients
responded well, it was continued for
9 months. If patients fail to lose
weight with it, they were
randomised to LighterLife VLED
(550 kcal day1) plus group support
weekly or a low carbohydrate/high
protein (800–1500 kcal day1) diet
for 9 months
Duration of active intervention:
12 months
Length of follow-up (months): 12
Packianathan 2005 (30) Location: England, no other
details
Design: Longitudinal study
Period of the study: Priori to July
2005
Inclusion criteria: Women, aged
35–65 years, with a BMI 35–45
Exclusion criteria: If women were
dieting, had a secondary cause of
obesity, were on drugs known to
Delivered by: Dietitian and
physicians
Description: Phase 1 included a 16-
week acute weight loss intervention
with 900 kcal day1 with SlimFast
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Recruitment: Through
advertisements in
local news media
Number of participants
allocated: 150
affect energy balance, had a history
of eating disorder, had lactose
intolerance or had significant
comorbidity
Baseline age, mean (SD):48.5 (8.3)
Comorbidities at baseline:
Excluded if participants had a
comorbidity
plus biweekly for a one hour dietetic
and cognitive behavioural therapy.
Second phase up to 10 SlimFast
meal replacements/week, optional
900 kcal day1 for relapse, or
patients could choose a low-fat diet
with a 600 kcal day1 energy
deficit, plus group dietetic and
lifestyle therapy, behavioural
modification and advice on
increased physical activity
Duration of active intervention:
12 months
Length of follow-up (months): 12
Jennings 2014 (24) Location: NHS Fakenham weight
management service, England
Design: Cohort study
Period of the study: 2011–2012
Recruitment: Referrals were
accepted from General
Practitioners
Number of participants
allocated: 230
Inclusion criteria: Age >18 years
with a BMI of ≥40 kg m2 or ≥
35 kg m2 with associated
comorbidities and/or waist
circumference ≥102 cm in men or
≥88 cm in women
Exclusion criteria: pregnancy,
severe eating disorder, poor
motivation identified by a
motivational questionnaire, or
failure to respond to an invitation
to contact the service
Baseline age, mean (SD): 52.7
(13.6)
Comorbidities at baseline: 31.7%
had diabetes, 0.43% had impaired
fasting glycaemia, 11.7% had
ischaemic heart disease, 38.3% had
hypertension, 11.7% had sleep
apnoea and 31.3% had depression
Delivered by: General practitioner
with additional training as a bariatric
physician, specialist nurses, dietitian,
psychological therapist, exercise
professional, health trainer and
supported by a consultant
endocrinologist and public health
consultant
Description: The service aimed to
deliver interventions including
medical assessment, motivational
interviewing to support behaviour
change, dietary and activity advice,
psychological therapies, drug
therapy with orlistat, medically
supervised LEDs and assessment for
suitability for bariatric surgery. The
exercise professional provided both
individual and small group sessions
at the on-site gym, and there was a
12-week exercise referral scheme
using local gyms. The number of
visits ranged from 10–15 visits for
the 1-year programme
Duration of active intervention:
12 months
Length of follow-up (months): 12
Ryan 2017 (35) Location: NHS Specialist weight
management service in the North
East of England
Design: Retrospective study
Period of the study: 2013–2014
Recruitment: Participants were
referred by General practitioners
Number of participants
allocated: 167
Inclusion criteria: BMI of
≥40 kg m2 or ≥ 35 kg m2 with
associated comorbidities, registered
with a local GP; aged >16 years;
with an ability to take charge of
their dietary intake; assessed as
‘ready to change’; and have had
previous attempts at weight loss
Exclusion criteria: suspected or
diagnosed malignancy, pregnant, or
requiring post-bariatric care (unless
previously known to the service)
Baseline age, mean (SD): 52.2
(11.9)
Delivered by: Dietician,
physiotherapist, psychologist,
metabolic physician/endocrinologist,
GP with a specialist interest in
obesity management
Description: In phase 1, patents
initially received an individual care
plan that included an exercise and
physical activity plan; outcomes
expected; target weight; behavioural
goals; and other tools and
educational materials. In phase 2,
patients move into group services
and treatment according to their
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Comorbidities at baseline: Not
reported
specific needs and care plan. In
phase 3, patients were discharged
from the service with details of the
patient’s outcomes and an ongoing
care plan sent to their GP
Duration of active intervention:
12 months
Length of follow-up (months): 12
Steele 2017 (36)
Aintree LOSS
Location: Hospital clinic, General
Practice (GP) surgeries,
community centres and a sports
centre in Liverpool, England
Design: Retrospective study
Period of the study: 2009–2013
Recruitment: Based primarily in
the community, and referrals are
predominantly received from
primary care teams, although
referrals are also accepted from
elsewhere, including secondary
care and community dietetics
Number of participants
allocated: 2457
Inclusion criteria: BMI of
≥40 kg m2 or ≥ 35 kg m2 with
associated comorbidities
Exclusion criteria: Not reported
Baseline age, mean (SD): 48.6
(13.8)
Comorbidities at baseline: 26%
had diabetes, 21.7% had sleep
apnoea, 47.7% had depression,
39.8% had hypertension, 32.4%
had hyperlipidaemia, 5.2% had
myocardial infarction, 6.8% had
ischaemic heat disease, 3.3% had
stroke and 47.3 had join pain
Delivered by: General practitioners,
physician with a special interest in
obesity, dieticians and
physiotherapists psychologists and
occupational therapists
Description: A personalised
management plan agreed from a list
of dietetics, physiotherapy,
occupational therapy and cognitive
analytical and behavioural therapy,
as well as group sessions (joint
physiotherapy, dietetics and
hydrotherapy). Group sessions run
for 2 h per week for 12 weeks.
Individual reviews took place every 1
to 3 months depending on the
intensity of intervention required.
Contact with leisure services via
swimming session was offered.
Orlistat was offered as an option to
participants
Duration of active intervention:
24 months
Length of follow-up (months): 24
Logue 2014 (27) Location: NHS, Glasgow and
Clyde Weight Management
Service, Scotland
Design: Prospective observational
study
Period of the study: 2008–2011
Recruitment: Referred by their GP
or hospital doctor
Number of participants
allocated: 1838
Inclusion criteria: Aged ≥18 years
with a BMI of ≥35 kg m2 or
≥30 kg m2 with associated
comorbidities
Exclusion criteria: Not reported
Baseline age, mean (SD): 49.1
(13.5)
Comorbidities at baseline: Not
reported
Delivered by: Service lead, team
leaders, dieticians, clinical
psychologists, psychology assistant,
physiotherapists, administrative staff
and technical support staff
Description: Educational lifestyle
programme that included cognitive
behavioural therapy and
600 kcal day1 deficit diet and
physical activity advice. Phase 1
comprised nine fortnightly 90 min
sessions over a 16 weeks. Then
patients could choose to enter
phase 2 (three 1 h sessions delivered
at monthly intervals plus a range of
treatment options including further
lifestyle advice, prescribed low
calorie diet or orlistat). At the end
of phase 2, or directly from the end
of phase 1, patients could enter a
weight maintenance programme
(3rd phase) comprising twelve
monthly 1 h sessions. Patients who
M. Aceves-Martins et al. UK-based interventions for severe obesity
21ª 2020 The Authors. Journal of Human Nutrition and Dietetics published by John Wiley & Sons Ltd
on behalf of British Dietetic Association.
Appendix Continued
Study (first author, year,
reference) Study characteristics Participant´s characteristics Intervention characteristics
fail to achieve their target weight
loss could choose to repeat phase 2
once more and then enter the
maintenance programme or opt for
bariatric surgery
Duration of active intervention:
12 months
Length of follow-up (months): 12
Wallace 2015 (37) The
‘Live Life Better’ Service
Location: NHS weight
management service from
Derbyshire County, England
Design: Cohort study
Period of the study: 2010–2013
Recruitment: Referred by their GP
or hospital doctor
Number of participants
allocated: 551
Inclusion criteria: BMI of
≥40 kg m2 or ≥ 35 kg m2 with
associated comorbidities
Exclusion criteria: Not reported
Baseline age, mean (SD): 45.7
(13.3)
Comorbidities at baseline: 33.2%
had hypertension, 3.8% had
ischaemic heart disease, 22.1% had
diabetes, 1.1% had stroke, 16.3%
had asthma, 24.9% chronic join
problems, 11.8% osteoarthritis
Delivered by: Psychologist, dietitian
or physiotherapist
Description: An intensive lifestyle
modification-based programme
involving psychological support,
behaviour change strategies,
physical activity, dietetic advice and
occupational therapy where
relevant. (No further details are
provided)
Duration of active intervention:
24 months
Length of follow-up (months): 24
Commercial programmes
Rolland 2014 (34)
LighterLife Total
Location: Scotland
Design: Retrospective study
Period of the study: 2007–2010
Recruitment: Self-referred
Number of participants
allocated: 5965
Inclusion criteria: ≥ 30 kg m2
Exclusion criteria: Type 1 diabetes,
porphyria, lactose intolerance,
major cardiovascular or
cerebrovascular disease, history of
renal disorder or hepatic disease,
cancer; epilepsy, major depressive
major psychiatric or eating
disorders, pregnant or
breastfeeding, have given birth or
had a miscarriage in the last 3
months
Baseline age, mean (SD): 45.6
(10.2)
Comorbidities at baseline: Not
reported
Delivered by: ‘Trained weight
management counsellors’
Description: LighterLife Total VLED
programme (550 kcal day1) and
group support (in small, single-sex,
weekly groups for the facilitation of
behaviour change for the treatment
of obesity), along with behavioural
therapy. Duration of active
intervention: Not reported
Length of follow-up (months): 12
GP, general practitoner; LED, low-energy formula diet (800–1200 kcal day1); VLED, very-low-energy formula diet (<800 kcal day1).
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